These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 25173767)

  • 1. Anaesthetic management during open and percutaneous irreversible electroporation.
    Nielsen K; Scheffer HJ; Vieveen JM; van Tilborg AA; Meijer S; van Kuijk C; van den Tol MP; Meijerink MR; Bouwman RA
    Br J Anaesth; 2014 Dec; 113(6):985-92. PubMed ID: 25173767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and safety of irreversible electroporation (IRE) in patients with small renal masses: Results of a prospective study.
    Buijs M; Zondervan PJ; de Bruin DM; van Lienden KP; Bex A; van Delden OM
    Urol Oncol; 2019 Mar; 37(3):183.e1-183.e8. PubMed ID: 30509869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Irreversible electroporation: local, non-thermal, ablation therapy of malignant tumours].
    Janík V; Skrabalová D; Gürlich R; Málek J
    Cas Lek Cesk; 2013; 152(2):67-75. PubMed ID: 23641678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial).
    Wendler JJ; Porsch M; Nitschke S; Köllermann J; Siedentopf S; Pech M; Fischbach F; Ricke J; Schostak M; Liehr UB
    Contemp Clin Trials; 2015 Jul; 43():10-9. PubMed ID: 25962890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible Electroporation in Hepatopancreaticobiliary Tumours.
    Ruarus AH; Vroomen LGPH; Puijk RS; Scheffer HJ; Zonderhuis BM; Kazemier G; van den Tol MP; Berger FH; Meijerink MR
    Can Assoc Radiol J; 2018 Feb; 69(1):38-50. PubMed ID: 29458954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ablation of colorectal liver metastases by irreversible electroporation: results of the COLDFIRE-I ablate-and-resect study.
    Scheffer HJ; Nielsen K; van Tilborg AA; Vieveen JM; Bouwman RA; Kazemier G; Niessen HW; Meijer S; van Kuijk C; van den Tol MP; Meijerink MR
    Eur Radiol; 2014 Oct; 24(10):2467-75. PubMed ID: 24939670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pain After Percutaneous Irreversible Electroporation of Renal Tumors Is Not Dependent on Tumor Location.
    Sorokin I; Lay AH; Reddy NK; Canvasser NE; Chamarthy M; Cadeddu JA
    J Endourol; 2017 Aug; 31(8):751-755. PubMed ID: 28586250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy.
    Scheffer HJ; Nielsen K; de Jong MC; van Tilborg AA; Vieveen JM; Bouwman AR; Meijer S; van Kuijk C; van den Tol PM; Meijerink MR
    J Vasc Interv Radiol; 2014 Jul; 25(7):997-1011; quiz 1011. PubMed ID: 24656178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac impact of high-frequency irreversible electroporation using an asymmetrical waveform on liver in vivo.
    Li J; Wang J; Zhang X; Zhang X; Gao H; Xiao Y
    BMC Cardiovasc Disord; 2021 Dec; 21(1):581. PubMed ID: 34876030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Irreversible Electroporation Ablation as Adjunctive Treatment for Margin Enhancement: Safety and Efficacy.
    Simmerman E; Chung J; Lawson A; Kruse E
    J Surg Res; 2020 Feb; 246():260-268. PubMed ID: 31610354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study.
    Scheffer HJ; Vroomen LG; de Jong MC; Melenhorst MC; Zonderhuis BM; Daams F; Vogel JA; Besselink MG; van Kuijk C; Witvliet J; de van der Schueren MA; de Gruijl TD; Stam AG; van den Tol PM; van Delft F; Kazemier G; Meijerink MR
    Radiology; 2017 Feb; 282(2):585-597. PubMed ID: 27604035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac synchronization and arrhythmia during irreversible electroporation.
    O'Neill CH; Martin RCG
    J Surg Oncol; 2020 Sep; 122(3):407-411. PubMed ID: 32483842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irreversible electroporation: a new challenge in "out of operating theater" anesthesia.
    Ball C; Thomson KR; Kavnoudias H
    Anesth Analg; 2010 May; 110(5):1305-9. PubMed ID: 20142349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous irreversible electroporation for the treatment of colorectal cancer liver metastases with a proposal for a new response evaluation system.
    Hosein PJ; Echenique A; Loaiza-Bonilla A; Froud T; Barbery K; Rocha Lima CM; Yrizarry JM; Narayanan G
    J Vasc Interv Radiol; 2014 Aug; 25(8):1233-1239.e2. PubMed ID: 24861662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible Electroporation for Hepatic Tumors: Protocol Standardization Using the Modified Delphi Technique.
    Ruarus AH; Barabasch A; Catalano O; Leen E; Narayanan G; Nilsson A; Padia SA; Wiggermann P; Scheffer HJ; Meijerink MR
    J Vasc Interv Radiol; 2020 Nov; 31(11):1765-1771.e15. PubMed ID: 32978054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial Assessment of the Efficacy of Irreversible Electroporation in the Focal Treatment of Localized Renal Cell Carcinoma With Delayed-interval Kidney Tumor Resection (Irreversible Electroporation of Kidney Tumors Before Partial Nephrectomy [IRENE] Trial-An Ablate-and-Resect Pilot Study).
    Wendler JJ; Pech M; Fischbach F; Jürgens J; Friebe B; Baumunk D; Porsch M; Blaschke S; Schindele D; Siedentopf S; Ricke J; Schostak M; Köllermann J; Liehr UB
    Urology; 2018 Apr; 114():224-232. PubMed ID: 29305201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of resistance as a measure of successful tumor ablation during irreversible electroporation of the pancreas.
    Dunki-Jacobs EM; Philips P; Martin RC
    J Am Coll Surg; 2014 Feb; 218(2):179-87. PubMed ID: 24315888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First Delayed Resection Findings After Irreversible Electroporation (IRE) of Human Localised Renal Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Trial.
    Wendler JJ; Ricke J; Pech M; Fischbach F; Jürgens J; Siedentopf S; Roessner A; Porsch M; Baumunk D; Schostak M; Köllermann J; Liehr UB
    Cardiovasc Intervent Radiol; 2016 Feb; 39(2):239-50. PubMed ID: 26341653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac impact of R-wave triggered irreversible electroporation therapy.
    Kostrzewa M; Tueluemen E; Rudic B; Rathmann N; Akin I; Henzler T; Liebe V; Schoenberg SO; Borggrefe M; Diehl SJ
    Heart Rhythm; 2018 Dec; 15(12):1872-1879. PubMed ID: 30017817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of irreversible electroporation treatment in hepatobiliary and pancreatic tumours: a single-centre experience.
    Fang C; Kibriya N; Heaton ND; Prachalias A; Srinivasan P; Menon K; Peddu P
    Clin Radiol; 2021 Aug; 76(8):599-606. PubMed ID: 33934875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.